Latest
8 Dec 2023 20:08
IN BRIEF: Novartis welcomes "significant milestone" for Kisqali
Novartis AG - Basel, Switzerland-based pharmaceuticals company - Reports Kisqali NATALEE analysis reinforces 25% reduction in risk of recurrence acros...
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
News & RNS
Latest News
8 Dec 2023 18:36
IN BRIEF: UK Oil & Gas receives payment from Horse Hill Developments
UK Oil & Gas PLC - London-based exploration and production company focused on UK and Turkey - Says that the "continued profitability" of the Horse Hil...
8 Dec 2023 18:33
IN BRIEF: Technology Minerals notes completion of sampling at Leinster
Technology Minerals PLC - London-based battery metals and recycling firm - Says that Global Battery Metals Ltd has completed a shallow trench samplin...
8 Dec 2023 18:33
IN BRIEF: HgCapital Trust agrees sale of GGW Group with Permira
HgCapital Trust PLC - London-based investor, providing access to the private equity investments of New York-based manager Hg - Says that it has agreed...
Latest RNS
View all RNS
Most Read
- 1PRESS RELEASE: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus26 Jun 2010 15:00
- 2Chesnara appoints Tom Howard from Aviva as chief financial officer7 Dec 2023 10:58
- 3LifeSafe Holdings signs deals as launches fluid for battery packs7 Dec 2023 14:31
- 4IN BRIEF: Novartis welcomes "significant milestone" for Kisqali8 Dec 2023 20:08
- 5LONDON BROKER RATINGS: Goldman lifts Landsec and British Land5 Dec 2023 10:02
- 1PRESS RELEASE: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus26 Jun 2010 15:00
- 2PipeHawk shares plunge as loss widens on higher costs29 Nov 2023 11:53
- 3LONDON BRIEFING: Ashtead in record half-year; tinyBuild cuts outlook5 Dec 2023 07:48
- 4LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew3 Nov 2023 09:31
- 5LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index4 Dec 2023 16:56
- 1PRESS RELEASE: 52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added to Metformin Was Non-Inferior to Titrated Glipizide When Added to Metformin in Reducing Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus26 Jun 2010 15:00
- 2TRADING UPDATES: Actual Experience appoints administrators7 Nov 2023 18:11
- 3TOP NEWS: Halma profit grows, ups dividend as eyes further profit rise16 Nov 2023 08:42
- 4LONDON BRIEFING: L&G agrees GBP4.8b buy-in for Boots Pension Scheme24 Nov 2023 07:50
- 5LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew3 Nov 2023 09:31